ClearEdge Balance System

Apparatus, Vestibular Analysis

Quadrant Biosciences

The following data is part of a premarket notification filed by Quadrant Biosciences with the FDA for Clearedge Balance System.

Pre-market Notification Details

Device IDK183661
510k NumberK183661
Device Name:ClearEdge Balance System
ClassificationApparatus, Vestibular Analysis
Applicant Quadrant Biosciences 505 Irving Avenue Syracuse,  NY  13210
ContactBryan Greene
CorrespondentBryan Greene
Quadrant Biosciences 505 Irving Avenue Syracuse,  NY  13210
Product CodeLXV  
CFR Regulation Number510(k) Premarket Notification [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received2018-12-27
Decision Date2019-10-22
Summary:summary

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.